Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • DRUGS AND BIOLOGICS—U.S.: Three states file Supreme Court challenge against Democratic states’ shield laws
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—OTHER AGENCY DOCUMENTS: Market forces shape Medicare spending beyond payment rules
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—E.D. Tenn.: McKesson brought about the proper removal of an opioid diversion case to federal court
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—GAO REPORTS: GAO recommends DEA and FDA update policies on drug scheduling processes
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ENFORCEMENT ACTIONS—NOTICES: DEA revokes registration over federal health program exclusion
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • GENERAL HEALTH CARE NEWS—M.D. La.: Claim against MSA administrator for underpayment of medical bills dismissed
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • HEALTH CARE EMPLOYMENT ISSUES—7th Cir.: Hospital pharmacist’s vaccine-bias suit fails over accommodation hardship
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ORGAN PROCUREMENT AND TRANSPLANTATION—NOTICES: HRSA finalizes donor-focused organ donation reimbursement rules
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • SAFETY AND EFFECTIVENESS—NOTICES: FDA withdraws MYSOLINE suspension approval after manufacturer waives hearing rights
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—E.D. Tenn.: McKesson brought about the proper removal of an opioid diversion case to federal court, (Oct 1, 2026)

    Law Firms Mentioned:Herzfeld Suetholz Gastel Leniski and Wall PLLC
    Organizations Mentioned:Covington & Burling, LLP | McKesson Corp. | Office of Personnel Management | Sherwin-Williams

    By Justin Marcus Smith, J.D.

    The federal officer removal statute applies when federal conduct is implicated, and even if that conduct is not challenged, a disclaimer about that is not enough to overcome allegations of conduct related to an act under color of federal office.

    Remov ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use